The Purdue/Mundipharma/Napp independent associated companies are privately-held companies engaged in the research, development, production, marketing, sales, distribution and licensing of prescription and over-the-counter medicines, as well as hospital products.

Worldwide leaders in the development and marketing of analgesic therapeutics for cancer and non-cancer pain, the Purdue/Mundipharma/Napp independent associated companies have particular expertise in the development of drug delivery systems that have been successfully applied to a range of analgesics, respiratory treatments, and cardiovascular drugs. They are also strong in the antiseptic and laxative markets. The Purdue/Mundipharma/Napp independent associated companies are also active in CNS discovery and development, and have a biologics therapeutics business focused on antibody-based therapeutics and vaccines.

The independent associated companies have prospered through innovative developments of essential medicines, the strengths of the Purdue/Mundipharma/Napp independent associated companies also include proven success in third party collaborations and licensing, and the capability to provide full development, medical, registration and manufacturing operations.

Worldwide these companies employ over 5,100 employees. In 2002 total sales of products amounted to approximately USD 1.9 billion.